Zeymer Uwe, Vogt Albrecht, Zahn Ralf, Weber Michael A, Tebbe Ulrich, Gottwik Martin, Bonzel Tassilo, Senges Jochen, Neuhaus Karl-Ludwig
Medizinische Klinik B, Herzzentrum Ludwigshafen, Ludwigshafen, Germany.
Eur Heart J. 2004 Feb;25(4):322-8. doi: 10.1016/j.ehj.2003.12.008.
Aims Acute myocardial infarction complicated by cardiogenic shock is associated with an exceedingly high mortality, even if patients are treated with early reperfusion therapy. The aim of this study was to evaluate predictors of in-hospital mortality of a large cohort of consecutive patients with cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Methods and results Between July 1994 and March 2001 all interventions performed in 80 centres in Germany were prospectively entered into the primary PCI registry of the ALKK. A total of 9422 procedures were registered, of these 1333 (14.2%) were performed in patients with cardiogenic shock. Total in-hospital mortality was 46.1% and was dependent on TIMI flow grade after PCI, with mortality rates of 78.2%, 66.1% and 37.4% in patients with TIMI 0/1, TIMI 2 and TIMI 3 flow, respectively. In a multivariate analysis left main disease, TIMI <3 flow after PCI, older age, three-vessel disease and longer time-intervals between symptom onset and PCI were significant independent predictors of mortality. The relative number of PCIs performed in patients with cardiogenic shock did not change significantly from 1995-2000. There was a significant decrease in mortality over the years (P for trend 0.02). Conclusions In-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock remains high, even with early interventional therapy. However, our data demonstrate that the PCI in these high-risk patients is feasible in a wide spectrum of community hospitals with acceptable success rates. Our results seen in connection with the results of the randomized SHOCK study advocate an early invasive approach in younger patients with cardiogenic shock, while the best strategy in elderly patients is still a matter of debate.
目的 急性心肌梗死合并心源性休克的死亡率极高,即便患者接受了早期再灌注治疗。本研究旨在评估一大群接受直接经皮冠状动脉介入治疗(PCI)的心源性休克连续患者的院内死亡率预测因素。方法与结果 1994年7月至2001年3月期间,德国80个中心进行的所有介入治疗均前瞻性地录入了ALKK的直接PCI登记系统。共登记了9422例手术,其中1333例(14.2%)是在心源性休克患者中进行的。院内总死亡率为46.1%,且取决于PCI后的TIMI血流分级,TIMI 0/1级、TIMI 2级和TIMI 3级血流的患者死亡率分别为78.2%、66.1%和37.4%。多变量分析显示,左主干病变、PCI后TIMI<3级血流、高龄、三支血管病变以及症状发作至PCI的时间间隔较长是死亡率的显著独立预测因素。1995 - 2000年期间,心源性休克患者接受PCI的相对数量没有显著变化。这些年来死亡率有显著下降(趋势P值为0.02)。结论 急性心肌梗死合并心源性休克患者即便接受早期介入治疗,院内死亡率仍然很高。然而,我们的数据表明,在众多社区医院中,对这些高危患者进行PCI是可行的,成功率也可接受。我们的结果与随机SHOCK研究的结果相结合,提倡对年轻的心源性休克患者采取早期侵入性治疗方法,而老年患者的最佳策略仍存在争议。